CTNNB1 and cervical carcinoma: Characterization of co‐expression signature associated with HEMO activation in TCGA datasets led us to hypothesize that its expression could be linked to the Wnt/β‐catenin pathway, in particular in endometrium tumors, where we found a clear association between the presence of CTNNB1 mutations and a high level of HEMO expression (73.6%).